维普中文期刊产品整合服务
36篇 您的检索式:作者名="Bleske"
    题名 作者 年代 出处 被引量
1Carvedilol:therapeutic application and practiceguidelines显示文摘Bleske BE Glibert EM Munger MA 1998Pharmacotherapy1998,18,:1
2Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure显示文摘 Welage LS Kramer WG 1998J Clin Pharmacol1998,38,8:1
3Effects of intravenous levosimendan on plasma neurohormone levels in patients with heart failure: relation to hemodynamic response显示文摘NICKLAS JM MONSUR JC BLESKE BE 1999Am J Cardiol1999,83,12:1
4Heart failure: clinical problem and management issues显示文摘Nicklas JM Bleske BE Van Harrison R 2013Prim Care2013,40,1:1
5Neutral effect on markers of heart failure,inflammation,endothelial activation and function,and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level显示文摘Bleske BE Nicklas JM Bard RL 2006J Am Coll Cardiol2006,47,2:1
6Clinical utility of azilsartan- chlorthalidone fixed combination in the management of hyperten- sion显示文摘Shuster JE Bleske BE Dorseh MP 2012Vasc Health Risk Manag2012,8,:1
7Effects of intravenous levosimendan on plasma neurohormone levels in patients with heart failure: relation to hemodynamic response显示文摘Nicklas JM Monsur JC Bleske BE 1999Am J Cardiol1999,83,1:1
8Evolution and the Trolley Problem: People Save Five Over One Unless the One Is Young, Genetically Related, Or a Romantic Partner显示文摘Bleske - Rechek A Lyndsay A N Jonathan P B 2010The Journal of Social Evolutionary and Cultural Psychology2010,4,3:1
9Food: an unrecognized source of loop diureticResistanee 显示文摘Bard RL Bleske BE Nicklas JM 2004Pharmacothcrapy2004,24,5:1
10Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and av- erage low-density lipoprotein level显示文摘Bleske BE Nicklas JM Bard RL 2006J Am Coil Cardiol2006,47,2:1
11Loading,pretreatment,and interindividual variability issues with clopidogrel dosing显示文摘Bates ER Lau WC Bleske BE 2005Circulation2005,111,20:1
12Acute effects of combination of IA and IB antiarrhythmias for the treatment of ventricular tachycardia显示文摘 Kluger J Fisher J 1989Clin Pharmacol1989,29,7:1
13Pharmacokintics of torasemide in patients with decompensated and compensated congestive heart failure显示文摘Blesks BE Welage LS Kramer WG 1998J Clin Armacol1998,38,8:1
14Tone after high-dose HMG-CoA reductase inhibition in non diabetic patients with non- ischemic cardiomyopathy and a-erage low-density lipoprotein le-el显示文摘Bleske BE Nicklas JM 2006J Am Coll Cardiol2006,47,2:1
15Comparison of adrenergic agonists for the treatment of ventricular fibrillation and pulseless electrical activity 显示文摘Bleske BE Billi JE 1994Resuscitation1994,28,3:1
16Clinical utility of azilsartan- chlorthalidone fixed combination in the management of hyper-tension显示文摘Shuster JE Bleske BE Dorsch MP 2012Vasc Health Risk Manag2012,8,:1
17Adaptations,exaptations,and spandrels显示文摘Buss D.M Haselton M.G Shackelford T.K Bleske A.L & Wakefield J.C 0,,:1
18Pharmacokinetics of torasemide in patients with decompensated and compensated congestive heart failure显示文摘Bleske BE Welage LS Kramer WG 1998J Clin Pharmacol1998,38,8:1
19The Effect of Continuous In-fusion Loop Diuretics in Patients With Acute Decompensated HeartFailure With Hypoalbuminemia 显示文摘Bleske BE Clark MM Wu AH’ 2013J Cardiovasc Pharmacol Ther2013,18,4:1
20Tone after high-dose HMG-CoA reduetase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level显示文摘Bleske B E Nicklas J M 2006J Am Coil Cardiol2006,47,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费